Novo Nordisk A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 4089
- Registration Number
- NCT05317845
- Locations
- 🇦🇪
Novo Nordisk Investigational Site, Abu Dhabi, United Arab Emirates
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 187
- Registration Number
- NCT05316662
- Locations
- 🇲🇽
Centro de Investigacion Clinica Endocrinologica de Jalisco, Guadalajara, Jalisco, Mexico
🇲🇽CICEJ Centro de Investigacion Clinica Endocrinologica de Jalisco SC, Guadalajara, Jalisco, Mexico
A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine.
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 65
- Registration Number
- NCT05314283
- Locations
- 🇳🇱
ICON - location Groningen, Groningen, Netherlands
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 221
- Registration Number
- NCT05308927
- Locations
- 🇫🇷
Novo Nordisk Investigational Site, Toulouse cedex 9, France
A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 70
- Registration Number
- NCT05306418
- Locations
- 🇺🇸
University of Iowa_Iowa City, Iowa City, Iowa, United States
🇺🇸Univ Hosp Cleveland Med Ctr, Cleveland, Ohio, United States
🇺🇸Penn State MS Hershey Med Ctr, Hershey, Pennsylvania, United States
A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump
- Conditions
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 19
- Registration Number
- NCT05262595
- Locations
- 🇦🇹
Novo Nordisk Investigational Site, Graz, Austria
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 683
- Registration Number
- NCT05259033
- Locations
- 🇺🇸
Pri Med Grp dba/Gil Ctr Fam, Gilbert, Arizona, United States
🇺🇸Diab & Endo Assoc of Stark Co, Canton, Ohio, United States
🇺🇸Sugar Lakes Family Practice PA, Sugar Land, Texas, United States
A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 24
- Registration Number
- NCT05254158
- Locations
- 🇨🇳
Novo Nordisk Investigational Site, Shanghai, Shanghai, China
Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 12404
- Registration Number
- NCT05250427
- Locations
- 🇻🇳
Novo Nordisk Investigational Site, Ho Chi Minh, Vietnam
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
- Conditions
- Interventions
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 500000
- Registration Number
- NCT05243823
- Locations
- 🇩🇰
Novo Nordisk Investigational Site, Soeborg, Denmark